share_log

三葉草生物-B：截至2024年6月30日止月份股份發行人的證券變動月報表

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2024

HKEX ·  Jul 3 18:14
Summary by Futu AI
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年7月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年6月30日的股份變動情況。報告顯示，公司的法定/註冊股本維持不變，總額為200,000美元，每股面值0.0001美元，總股份數目為2,000,000,000股。在已發行股份方面，公司在6月份僅增加了1,500股普通股，使得月底結存的已發行股份總數達到1,297,048,929股。此外，公司的股份期權計劃中，首次公開發售前購股權計劃及首次公開發售後購股權計劃均有所變動，其中後者因期權失效而減少了2,523,213股。公司確認所有證券發行或庫存股份的出售或轉讓均已獲得董事會正式授權批准，並遵守所有適用的上市規則、法律及其他監管規定。
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年7月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年6月30日的股份變動情況。報告顯示，公司的法定/註冊股本維持不變，總額為200,000美元，每股面值0.0001美元，總股份數目為2,000,000,000股。在已發行股份方面，公司在6月份僅增加了1,500股普通股，使得月底結存的已發行股份總數達到1,297,048,929股。此外，公司的股份期權計劃中，首次公開發售前購股權計劃及首次公開發售後購股權計劃均有所變動，其中後者因期權失效而減少了2,523,213股。公司確認所有證券發行或庫存股份的出售或轉讓均已獲得董事會正式授權批准，並遵守所有適用的上市規則、法律及其他監管規定。
On July 3, 2024, San Ye Cao Biotechnology Co., Ltd. ("San Ye Cao Biotechnology-B") submitted its latest monthly report on securities changes to Hong Kong Exchanges and Clearing Limited, reporting on the shareholding changes as of June 30, 2024. The report shows that the company's statutory/registered share capital remains unchanged, totaling USD 200,000 with a par value of USD 0.0001 per share, and a total number of issued shares of 2,000,000,000. In terms of issued shares, the company only increased its ordinary shares by 1,500 in June, bringing the total number of issued shares at the end of the month to 1,297,048,929. In addition, there have been changes in both the pre-ipo share option plan and the post-ipo share option plan in the company...Show More
On July 3, 2024, San Ye Cao Biotechnology Co., Ltd. ("San Ye Cao Biotechnology-B") submitted its latest monthly report on securities changes to Hong Kong Exchanges and Clearing Limited, reporting on the shareholding changes as of June 30, 2024. The report shows that the company's statutory/registered share capital remains unchanged, totaling USD 200,000 with a par value of USD 0.0001 per share, and a total number of issued shares of 2,000,000,000. In terms of issued shares, the company only increased its ordinary shares by 1,500 in June, bringing the total number of issued shares at the end of the month to 1,297,048,929. In addition, there have been changes in both the pre-ipo share option plan and the post-ipo share option plan in the company's share option plan, with the latter decreasing by 2,523,213 shares due to the options expiring. The company confirms that all sales or transfers of securities issued or in stock have been formally authorized and approved by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.